Actively Recruiting

Age: 18Years +
All Genders
NCT05679284

A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs

Led by Tampere University Hospital · Updated on 2023-06-01

100

Participants Needed

1

Research Sites

285 weeks

Total Duration

On this page

Sponsors

T

Tampere University Hospital

Lead Sponsor

D

Deaconess Foundation

Collaborating Sponsor

AI-Summary

What this Trial Is About

In addition to the well-known toxicological harms of intravenous drug (IVD) use, there can also be local tissue complications, including infections, venous sclerosis, tissue necrosis, and drug needle fragment retentions. Drug needle fragments in subcutaneous tissue may cause local symptoms (usually pain and infections), but they have also been identified as causing emboli to organs. The literature has described numerous case reports of people who inject drugs (PWIDs) and have retained needle fragments. The prevalence of the condition is not known, and the researchers therefore aim to perform the first cross-sectional study of PWIDs to estimate how common needle fragment retentions are and what their risk factors are in this population.

CONDITIONS

Official Title

A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • History of intravenous drug use
  • Currently receiving treatment for drug abuse at a local low-threshold drug abuse service unit or primary health care centre
  • Willingness and ability to complete the questionnaire
  • Willingness to participate in X-ray imaging of injection sites
Not Eligible

You will not qualify if you...

  • No history of intravenous drug use
  • Unwillingness or inability to complete the questionnaire or to undergo X-ray imaging
  • Pregnancy
  • Under 18 years old

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hatanpää Health Center

Tampere, Finland

Actively Recruiting

Loading map...

Research Team

O

Otso Arponen, Associate Professor, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here